No abstract available
Keywords:
cancer intervention; endocrine cancer; pancreatic cancer; radiology; therapeutic indications.
MeSH terms
-
Aged, 80 and over
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Biomarkers, Tumor / blood
-
Bone Neoplasms / metabolism
-
Bone Neoplasms / secondary
-
Bone Neoplasms / therapy
-
Chromogranin A / blood
-
Humans
-
Liver Neoplasms / metabolism
-
Liver Neoplasms / secondary
-
Liver Neoplasms / therapy
-
Lutetium / therapeutic use*
-
Male
-
Neuroendocrine Tumors / metabolism
-
Neuroendocrine Tumors / therapy*
-
Octreotide / analogs & derivatives*
-
Octreotide / therapeutic use
-
Organometallic Compounds / therapeutic use*
-
Pancreatic Neoplasms / metabolism
-
Pancreatic Neoplasms / therapy
-
Receptors, Peptide / metabolism
-
Remission Induction
Substances
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
Chromogranin A
-
Organometallic Compounds
-
Receptors, Peptide
-
Lutetium
-
lutetium Lu 177 dotatate
-
Octreotide